PBH
$34.85
Prestige Brand
($.37)
(1.05%)
PBH
Earnings Whisper ®
N/A
2nd Quarter September 2020
Consensus:  $0.72
Revenue:  $227.37 Mil
Thursday
Nov 5
6:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when PBH reports earnings?
Beat
Meet
Miss

Where is PBH's stock price going from here?
Up
Flat
Down
Stock chart of PBH
Analysts
Summary of analysts' recommendations for PBH
Score
Grade
Pivots
Resistance
$36.23
$35.77
$35.49

$35.03

Support
$34.75
$34.29
$34.01
Tweet
Growth
Description
Prestige Brands Holdings, Inc. markets and distributes brand name over-the-counter and household cleaning products, in certain international markets. The Company's brands include Monistat and Summer's Eve women's health products, BC and Goody's pain relievers, Clear Eyes eye care products, DenTek specialty oral care products, Dramamine motion sickness treatments, Chloraseptic sore throat treatments, Compound W wart treatments, Little Remedies pediatric over-the-counter products, The Doctor's NightGuard dental protector, Efferdent denture care products, Luden's throat drops, Beano gas prevention, Debrox earwax remover, Gaviscon antacid in Canada, and Hydralyte rehydration products and the Fess line of nasal and sinus care products. Prestige Brands is a different kind of company. They focus on product innovation and quality in the over-the-counter healthcare and household cleaning categories to better improve the lives of customers and their world.
Peers
InterCeptBioMarin PharmaceuticalRegeneron PharmaceuticalsVertex PharmaceuticalsZoetisJohnson & JohnsonUltragenyx PharmaceuticalMerck & Co.Bristol-Myers SquibbCatalent